Hyperuricemia clinical trials
The registry lists 214 studies for Hyperuricemia across more than 10 countries. 40 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-18.
Status
- Completed
- 119
- Status unknown
- 38
- Recruiting
- 27
- Not yet recruiting
- 12
- Active, not recruiting
- 9
- Terminated
- 6
Phase
- Phase 2
- 61
- Phase 1
- 38
- Phase 4
- 26
- Phase 3
- 19
- Early Phase 1
- 4
Where
- United States
- 68
- China
- 52
- Japan
- 19
- Taiwan
- 12
- France
- 7
- Italy
- 6
Who runs them
Jiangsu HengRui Medicine Co., Ltd. (12) · LG Chem (10) · Sanofi (9) · AstraZeneca (6) · Assiut University (6) · Allena Pharmaceuticals (5) · Fuji Yakuhin Co., Ltd. (5) · Arthrosi Therapeutics (5)
Studies
Recruiting first, then most recently updated. Showing 50 of 214 — search for more.
- Mazdutide for Weight Management and Gout in Adults With ObesityNot yet recruitingNCT07824895Phase 4
- A Study of Dotinurad Versus Allopurinol in Tophaceous GoutRecruitingNCT07089888Phase 31 country
- A Study of Dotinurad Versus Allopurinol in Participants With GoutRecruitingNCT07089875Phase 33 countries
- SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) TrialRecruitingNCT06674109Phase 41 country
- A Study of IN026 in Participants With Refractory GoutRecruitingNCT07587684Phase 11 country
- Evaluation of the Effect of Hyperuricemia on Alveolar Bone LossRecruitingNCT076661261 country
- Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic HyperuricemiaRecruitingNCT07613138Not applicable1 country
- A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)RecruitingNCT07280156Phase 23 countries
- Probiotic-Uricase Complex Preparation for Improving Uric Acid Metabolism in Patients With HyperuricemiaNot yet recruitingNCT07613164Not applicable
- The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and HyperuricemiaRecruitingNCT07362355Phase 21 country
- Chronic Kidney Disease and Metabolic Disorders in the ElderlyNot yet recruitingNCT074945261 country
- Clinical Trial of BR2251 Tablets for Patients With Primary Gout and HyperuricemiaNot yet recruitingNCT07498647Phase 2
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlareRecruitingNCT05658575Phase 2/35 countries
- Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)RecruitingNCT07400549Not applicable1 country
- A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney DiseaseRecruitingNCT06310967Phase 1/22 countries
- HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-EffectivenessNot yet recruitingNCT07369622Phase 4
- Acute Effects of a Urate-lowering Bacterial Therapeutic on Small Intestinal Transcriptomics and Glycomics in Healthy SubjectsNot yet recruitingNCT07366749Not applicable1 country
- Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT07053709
- Effect of Dotinurad in Hyperuricemia With HypertensionRecruitingNCT06834230Phase 41 country
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)RecruitingNCT047522931 country
- Hyperuricemia as Early Indication of CKD Progressing in PrediabeticNot yet recruitingNCT07199205
- A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaRecruitingNCT06859073Phase 11 country
- Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese PatientsNot yet recruitingNCT07168551
- This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering TherapyRecruitingNCT071443321 country
- Effects of Fibres Combined With Probiotics on Uric Acid in an ex Vivo Fermentation ModelRecruitingNCT069816631 country
- Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic HyperuricaemiaRecruitingNCT07002762Not applicable1 country
- Developing A Gout Action Plan in Primary Care Setting in SingaporeNot yet recruitingNCT07061587Not applicable1 country
- Metabolically Healthy Obesity Increases the Risks of MASLD and HyperuricemiaEnrolling by invitationNCT070018651 country
- Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and HyperuricemiaRecruitingNCT06629376Phase 11 country
- Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release TabletsRecruitingNCT06966635Phase 41 country
- Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA)RecruitingNCT06824376Not applicable1 country
- Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2RecruitingNCT066940121 country
- Screening and Management of Hyperuricemia in Patients with Chronic Medical Diseases in Assiut University HospitalNot yet recruitingNCT06586229
- Prebiotics and the Management of HyperuricemiaRecruitingNCT06420401Not applicable1 country
- Efficacy Study of Acupuncture on Asymptomatic HyperuricemiaRecruitingNCT05406830Not applicable1 country
- Impact of Hyperuricemia on Psoriatic ArthritisRecruitingNCT061254441 country
- Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial FibrillationRecruitingNCT061198021 country
- Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical TrialRecruitingNCT04199325Not applicable1 country
- Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With HyperuricemiaNot yet recruitingNCT05913310Phase 4
- Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic DiseasesRecruitingNCT054766271 country
- Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With GoutCompletedNCT02252835Phase 21 country
- Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With GoutCompletedNCT01336686Phase 21 country
- Long-Term Risk of Gout in Living Kidney DonorsActive, not recruitingNCT07546643
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)CompletedNCT06439602Phase 35 countries
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)Active, not recruitingNCT06846515Phase 31 country
- Uric Acid Lowering Trial in Youth Onset T2DCompletedNCT03899883Phase 21 country
- Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With HyperuricemiaCompletedNCT06056570Phase 1/21 country
- Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed PatientsActive, not recruitingNCT07116746Phase 21 country
- Identification and Characterization of At-risk MASLD in Turkish AdultsCompletedNCT075489701 country
- Treat-to-target by Email During Urate-lowering Therapy in GoutActive, not recruitingNCT04733079Not applicable1 country